Identifying Patients With Unrecognized Treatable Diabetic Macular Edema

N/AUnknownNCT01934920

Elman Retina Group500 enrolled

Overview

This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Diabetic Macular Edema

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Ability to provide written informed consent and comply with study assessments for the full duration of the study * Age \> 18 years * Patient related considerations * Patients with diabetes mellitus * Disease related considerations * Diabetes mellitus Exclusion Criteria: * Prior admission screening within twelve months. * Inability to sit for evaluation

Locations (2)

Aaron Goldberg, Primary Care

Baltimore, Maryland, United States

RECRUITING

MedStar Hospital

Baltimore, Maryland, United States

RECRUITING

Outcomes

Primary Outcomes

Assess the incidence of new and/or undiagnosed diabetic macular edema.

Time frame: 1 day (Patients are only seen once for assessments)

Secondary Outcomes

Streamlining and identification of patients at risk of diabetic macular edema

Establish methods for streamlining screening and identification of patients at risk. Establish methods for referral for treatment of patients identified with vision threatening diabetic retinopathy.

Time frame: 1 day (Patients only seen once for assessments)

Central Contacts

Jennifer Belz

CONTACT

4106863000 belz@elmanretina.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.